Chemosensitivity Assay: Clinical Trials

2 trials of Chemosensitivity Assay, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Terminated 1

Follow Chemosensitivity Assay: new trials by email Literature Review of Chemosensitivity Assay trials Research Report on Chemosensitivity Assay

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Carfilzomib, Chemosensitivity Assay, Dexamethasone - Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
Phase 2TerminatedUniversity of Washington92018-02-082022-05-09
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
Chemosensitivity Assay, Cytology Specimen Collection Procedure, Gene Expression Analysis - Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia
Not applicableCompletedUniversity of Washington342015-09-112022-06-30

Conditions studied

Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Multiple Myeloma (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

University of Washington (2)

Countries

United States (2)

Top investigators

Andrew Cowan (1)  ·  Mary-Elizabeth Percival (1)

NIH funding

P30CA015704 (2)